VEQUATAL Trademark

Trademark Overview


On Monday, October 13, 2014, a trademark application was filed for VEQUATAL with the United States Patent and Trademark Office. The USPTO has given the VEQUATAL trademark a serial number of 79158382. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 24, 2021. This trademark is owned by Novartis AG. The VEQUATAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, and diabetes; antifungal, anti...
vequatal

General Information


Serial Number79158382
Word MarkVEQUATAL
Filing DateMonday, October 13, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 24, 2021
Registration Number4750215
Registration DateTuesday, June 9, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, and diabetes; antifungal, anti-infective, and antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, March 29, 2023INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Wednesday, August 24, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 24, 2021CANCELLED SECTION 71
Friday, September 4, 2015NOTIFICATION PROCESSED BY IB
Monday, August 17, 2015FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 17, 2015FINAL DISPOSITION PROCESSED
Thursday, July 9, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 9, 2015REGISTERED-PRINCIPAL REGISTER
Friday, April 3, 2015NOTIFICATION PROCESSED BY IB
Tuesday, March 24, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 18, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 4, 2015NOTICE OF PUBLICATION
Monday, February 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 2, 2015ASSIGNED TO EXAMINER
Tuesday, January 13, 2015APPLICATION FILING RECEIPT MAILED
Thursday, January 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 7, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, January 2, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB